Company · founded 1961
Advanced Bioscience Laboratories (United States)
Rockville, United States · ablinc.com
- Citations, last 5 years
- 130
- Works, last 5 years
- 11
- h-index
- 96
- Scientists listed
- 4
- Grants since 2016
- 173
Grants received
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X12: Development of a Gonorrhea Vaccine
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task Order X5 Master Cell Bank for Chlamydia Trachoma Vaccine
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X6 Generation of a Shigella Vaccine
Norman Kneteman · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task Order 9 Master Cell Bank for Chlamydia Trachoma Vaccine
Norman Kneteman · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X1: Manufacture and Characterization Services for Vaccines and Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X13: Product Characterization and Process Development
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X20:Master Cell Banks
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health